What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis - Top-Institutions - MDSpire

What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis

  • By

  • Ziang Xu

  • Yikun Zhang

  • Yanyu Huo

  • Zihua Xu

  • Chenze Wang

  • Chengkang Wang

  • Yingshi Zhang

  • Qingchun Zhao

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Weill Cornell Medical College
    Weill Cornell Medical College

    New York, New York

    Key Differentiators

    • Oncology

  • #4

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, California

    Key Differentiators

    • Oncology

  • #5

    University of Padova
    University of Padova

    Padova, Italy

    Key Differentiators

    • Oncology

Original Source(s)

What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis

  • by Ziang Xu, Yikun Zhang, Yanyu Huo, Zihua Xu, Chenze Wang, Chengkang Wang, Yingshi Zhang, Qingchun Zhao

  • July 14, 2026

Related Content

Spatial transcriptomics reveals molecular differences associated with malignant transformation in oral epithelial dysplasia

Navigating the gut–metabolite–immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report